Tumor immune microenvironment is associated with the growth of intracranial germinomas

Masaaki Nishimoto, Kentaro Ohara, Dai Kamamoto, Ryota Tamura, Tomoru Miwa, Kazunari Yoshida, Hikaru Sasaki

Research output: Contribution to journalArticle

Abstract

Introduction: The role of immune checkpoint molecules and the tumor immune microenvironment in the development of intracranial germ cell tumors remains unclear. Methods: We investigated the expression of programed cell death-1 (PD-1), programed cell death ligand-1 (PD-L1), and tumor-infiltrating lymphocytes (TILs) in 8 patients who had intracranial germinomas with sufficient tumor tissue by immunohistochemistry, to analyze the associations between their clinical courses and radiological features. The 8 patients were categorized based on the duration between symptom onset and pathological diagnosis into the long-term onset (LTO) group (> 1 year of symptoms) and the short-term onset (STO) group (< 1 year of symptoms). Results: Three patients belonged to the LTO group and 5 patients to the STO group. Compared with STO tumors, LTO tumors were significantly associated with a lower ratio of PD-L1–positive tumor cells (p = 0.012), higher number of infiltrating CD3- and CD8-positive lymphocytes (p = 0.016, 0.003, respectively), and lower ratio of PD-1–positive cells per CD8-positive lymphocytes (p = 0.047). LTO germinomas were significantly smaller in size than STO tumors, not associated with hydrocephalus, and tended to be present in patients with older age at diagnosis and atypical tumor location. Conclusions: Our data suggest that the tumor immune microenvironment, including PD-1/PD-L1 signaling, is associated with the growth of intracranial germinomas.

Original languageEnglish
JournalJournal of Neuro-Oncology
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Fingerprint

Germinoma
Tumor Microenvironment
CD274 Antigen
Growth
CD8-Positive T-Lymphocytes
Neoplasms
Cell Death
Tumor-Infiltrating Lymphocytes
Germ Cell and Embryonal Neoplasms
Hydrocephalus
Immunohistochemistry

Keywords

  • Germ cell tumor
  • Intracranial germinoma
  • PD-1
  • PD-L1
  • Tumor immune microenvironment
  • Tumor-infiltrating lymphocyte

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Tumor immune microenvironment is associated with the growth of intracranial germinomas. / Nishimoto, Masaaki; Ohara, Kentaro; Kamamoto, Dai; Tamura, Ryota; Miwa, Tomoru; Yoshida, Kazunari; Sasaki, Hikaru.

In: Journal of Neuro-Oncology, 01.01.2019.

Research output: Contribution to journalArticle

@article{1589be3643bf4e2baeec35a046e5490c,
title = "Tumor immune microenvironment is associated with the growth of intracranial germinomas",
abstract = "Introduction: The role of immune checkpoint molecules and the tumor immune microenvironment in the development of intracranial germ cell tumors remains unclear. Methods: We investigated the expression of programed cell death-1 (PD-1), programed cell death ligand-1 (PD-L1), and tumor-infiltrating lymphocytes (TILs) in 8 patients who had intracranial germinomas with sufficient tumor tissue by immunohistochemistry, to analyze the associations between their clinical courses and radiological features. The 8 patients were categorized based on the duration between symptom onset and pathological diagnosis into the long-term onset (LTO) group (> 1 year of symptoms) and the short-term onset (STO) group (< 1 year of symptoms). Results: Three patients belonged to the LTO group and 5 patients to the STO group. Compared with STO tumors, LTO tumors were significantly associated with a lower ratio of PD-L1–positive tumor cells (p = 0.012), higher number of infiltrating CD3- and CD8-positive lymphocytes (p = 0.016, 0.003, respectively), and lower ratio of PD-1–positive cells per CD8-positive lymphocytes (p = 0.047). LTO germinomas were significantly smaller in size than STO tumors, not associated with hydrocephalus, and tended to be present in patients with older age at diagnosis and atypical tumor location. Conclusions: Our data suggest that the tumor immune microenvironment, including PD-1/PD-L1 signaling, is associated with the growth of intracranial germinomas.",
keywords = "Germ cell tumor, Intracranial germinoma, PD-1, PD-L1, Tumor immune microenvironment, Tumor-infiltrating lymphocyte",
author = "Masaaki Nishimoto and Kentaro Ohara and Dai Kamamoto and Ryota Tamura and Tomoru Miwa and Kazunari Yoshida and Hikaru Sasaki",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s11060-019-03355-0",
language = "English",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",

}

TY - JOUR

T1 - Tumor immune microenvironment is associated with the growth of intracranial germinomas

AU - Nishimoto, Masaaki

AU - Ohara, Kentaro

AU - Kamamoto, Dai

AU - Tamura, Ryota

AU - Miwa, Tomoru

AU - Yoshida, Kazunari

AU - Sasaki, Hikaru

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: The role of immune checkpoint molecules and the tumor immune microenvironment in the development of intracranial germ cell tumors remains unclear. Methods: We investigated the expression of programed cell death-1 (PD-1), programed cell death ligand-1 (PD-L1), and tumor-infiltrating lymphocytes (TILs) in 8 patients who had intracranial germinomas with sufficient tumor tissue by immunohistochemistry, to analyze the associations between their clinical courses and radiological features. The 8 patients were categorized based on the duration between symptom onset and pathological diagnosis into the long-term onset (LTO) group (> 1 year of symptoms) and the short-term onset (STO) group (< 1 year of symptoms). Results: Three patients belonged to the LTO group and 5 patients to the STO group. Compared with STO tumors, LTO tumors were significantly associated with a lower ratio of PD-L1–positive tumor cells (p = 0.012), higher number of infiltrating CD3- and CD8-positive lymphocytes (p = 0.016, 0.003, respectively), and lower ratio of PD-1–positive cells per CD8-positive lymphocytes (p = 0.047). LTO germinomas were significantly smaller in size than STO tumors, not associated with hydrocephalus, and tended to be present in patients with older age at diagnosis and atypical tumor location. Conclusions: Our data suggest that the tumor immune microenvironment, including PD-1/PD-L1 signaling, is associated with the growth of intracranial germinomas.

AB - Introduction: The role of immune checkpoint molecules and the tumor immune microenvironment in the development of intracranial germ cell tumors remains unclear. Methods: We investigated the expression of programed cell death-1 (PD-1), programed cell death ligand-1 (PD-L1), and tumor-infiltrating lymphocytes (TILs) in 8 patients who had intracranial germinomas with sufficient tumor tissue by immunohistochemistry, to analyze the associations between their clinical courses and radiological features. The 8 patients were categorized based on the duration between symptom onset and pathological diagnosis into the long-term onset (LTO) group (> 1 year of symptoms) and the short-term onset (STO) group (< 1 year of symptoms). Results: Three patients belonged to the LTO group and 5 patients to the STO group. Compared with STO tumors, LTO tumors were significantly associated with a lower ratio of PD-L1–positive tumor cells (p = 0.012), higher number of infiltrating CD3- and CD8-positive lymphocytes (p = 0.016, 0.003, respectively), and lower ratio of PD-1–positive cells per CD8-positive lymphocytes (p = 0.047). LTO germinomas were significantly smaller in size than STO tumors, not associated with hydrocephalus, and tended to be present in patients with older age at diagnosis and atypical tumor location. Conclusions: Our data suggest that the tumor immune microenvironment, including PD-1/PD-L1 signaling, is associated with the growth of intracranial germinomas.

KW - Germ cell tumor

KW - Intracranial germinoma

KW - PD-1

KW - PD-L1

KW - Tumor immune microenvironment

KW - Tumor-infiltrating lymphocyte

UR - http://www.scopus.com/inward/record.url?scp=85076214229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076214229&partnerID=8YFLogxK

U2 - 10.1007/s11060-019-03355-0

DO - 10.1007/s11060-019-03355-0

M3 - Article

C2 - 31773448

AN - SCOPUS:85076214229

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

ER -